People who use alcohol and other drugs(hereafter "substances") and who are over the age of 40 are now more likely to die of a non-drug related cause than people who use substances under the age of 40. This population will therefore potentially need greater access to palliative and end of life care services. Initially, the purpose of this rapid evidence assessment (REA), conducted August 2016-August 2017, was to explore the peer-reviewed evidence base in relation to end of life care for people with problematic substance use. The following databases were searched using date parameters of 1 January 2004-1 August 2016: Amed, Psycharticles, Ovid, Ageinfo, Medline, Ebscohost, ASSIA, Social Care Online, Web of Knowledge, Web of Science, SSCI, Samsha, NIAAA. Data were extracted using a predefined protocol incorporating inclusion and exclusion criteria. Given the dearth of evidence emerging on interventions and practice responses to problematic substance use, the inclusion criteria were broadened to include any peer-reviewed literature focussing on substance use specifically and end of life care. There were 60 papers that met the inclusion criteria. These were quality assessed. Using a textual thematic approach to categorise findings, papers fell into three broad groups (a) pain management, (b) homeless and marginalised groups, and (c) alcohol-related papers. In general, this small and diverse literature lacked depth and quality. The papers suggest there are challenges for health and social care professionals in meeting the end of life needs of people who use substances. Addressing issues like safe prescribing for pain management becomes more challenging in the presence of substance use and requires flexible service provision from both alcohol/drug services and end of life care providers. Work is needed to develop models of good practice in working with co-existing substance use and end of life conditions as well as prevalence studies to provide a wider context for policy development. 
| BACKG ROU N D
In the last 20 years there have been numerous changes evident among the population who use substances whether this be alcohol or other drugs. The most important changes appear to be an increase in the number of older drugs users, a subsequent rise in rates of death from non-drug related conditions (Beynon, 2010) , an increase in alcohol-related morbidity among older users (Kaplan et al., 2012) and the burgeoning of New Psychoactive Substances (NPS) use. The increase in older drug users may be associated with changes to the treatment management for illicit opiate users in the 1990's (McKeganey, 2006) and, in particular, the expansion and greater availability of methadone prescription (Clausen, 2008; Clausen, Waal, Thoresen, & Gossop, 2009 ). This increased availability means that increasing numbers of people with current and previous substance use have better survival rates and are more likely to die from the same chronic conditions that affect the general population (Corkery, 2008; Beynon et al., 2010) . It may be that some of this population are using substances for longer or commencing drug use later in life but, whatever the cause, there has been an increase in older drug users accessing drug treatment services in the UK (Beynon, 2010; Beynon et al., 2010) .
Before methadone treatment programmes were introduced, people who used substances had a greater risk of dying from overdoses (deliberate or accidental), as well as accidents, violence and disease.
These could be related to the substance itself or its route of administration, such as liver disease, HIV (Human Immunodeficiency Virus) and bacterial infections (Gibson et al., 2008) . The adoption of evidence-based interventions like supervised injecting facilities, needle exchange programmes and outreach programmes for illicit drug users is considered to be an effective overarching policy approach for reducing harm (Ritter & Cameron, 2006) . Harm reduction policies and related treatment approaches have led to older substance users (over the age of 40) now being more likely to die of a non-drug related cause than people using substances under the age of 40 (Benyon et al., 2010; Stenbacka et al., 2008) . However, people using substances are still more likely to die at an earlier age than the general population and have patterns of disease and morbidity that reflect the impact of substance use or the traumatic life experiences more frequently encountered in this group (Beynon, Roe, Duffy, & Pickering, 2009; Beynon et al., 2010) . In addition, there are higher rates of alcoholrelated morbidity and mortality associated with chronic and acute alcohol problems (Chang, Kreis, Wong, Simpson, & Guymer, 2008; Shield, Parry, & Rehm, 2014; Taylor et al., 2010) . This highlights a more nuanced picture of alcohol-related harm given that the highest consumption is among more affluent groups of the population (Office for National Statistics, 2017) but the highest rates of alcoholrelated problems are among the least affluent (Erskine, Maheswaran, Pearson, & Gleeson, 2010) .
The final set of changes is the increase in the use of NPS. Some of the more immediate consequences of NPS use are evident in the prisons system and in admissions to hospital accident and emergency departments for acute intoxication (Liakoni, Dolder, Rentsch, & Liechti, 2016; Ralphs, Williams, Ashew, & Norton, 2017) . These harmful consequences are particularly associated with people who are homeless (Henshall et al., 2018) . The impact of NPS use on mortality and morbidity, both medium and long-term has yet to be evaluated.
While there has been an improvement in life expectancy within the general population, it has been associated with more years living with poor health or disability at the end of life (Bell & Marmot, 2017) . This has subsequently increased the anticipated number of deaths that are likely to need palliative and end of life care (Etkind et al., 2017 ). There appears to be only fragmented evidence relating to (a) the extent and nature of the care needs by people using substances and (b) the challenges services will face in supporting people with problematic substance use at the end of life. This Rapid Evidence Assessment (REA) aimed to explore what is already known about responses to end of life care need for people using substance and identify gaps in the evidence base. It forms one part of a wider programme of research on end of life care for people with problematic substance use (Galvani, Tetley, et al., 2016) .
| Conceptual framework
Within the current literature, discrete definitions of palliative as What is known about this topic
• There is an increase in older substance users who will require end of life care.
• Meeting end of life needs for this group of people will require flexible service provision.
• Problematic substance users often present with complex social and medical problems that make accessing formalised end of life care services more difficult to navigate than other populations.
What this paper adds
• This paper identifies and documents the limited evidence base that exists on end of life care for people with substance problems.
• It identifies gaps in the evidence relating to focus and methodology.
• It identifies examples of good practice and highlights fu- End of life care definitions can have limited clinical utility since recognising dying is difficult to assess or predict with many chronic conditions. For this REA, our end of life definition remains similar to the palliative care definition but the time scale is reduced to the last 12 months of life (General Medical Council, 2010) . For this REA we excluded tobacco and caffeine. Drugs refers to illicit drugs and the misuse of prescription medication. Substance use we initially defined as current or previous problematic alcohol or other drug use (prescribed or illicit) while receiving palliative or end of life care.
However, the dearth of literature resulted in the definition changing to include any alcohol or drug use, rather than problematic use, except we retained problematic prescription drug use to ensure manageability of the evidence.
| ME THODS

| Aims
The question to be addressed was; what does the existing international research and wider literature tell us about current responses to end of life care for people with substance problems? The question focussed initially on care responses and was broken down further into the following aims:
1. To explore and document the evidence base that already exists on responses to end of life care for people with substance problems.
2. To identify gaps in the evidence relating to focus and methodology.
3. To identify examples of good practice and to highlight future directions for research.
| Design
A Rapid Evidence Assessment (REA) methodology was identified as the most appropriate research tool to use to enable a speedy identification of key pieces of evidence. This would inform our wider study and provide a reference document to underpin further work on this topic in policy or practice. REAs can be defined as providing.
'… a more structured and rigorous search and quality assessment of the evidence than a literature review' but one critique is that it has narrower parameters and is not "as exhaustive as a systematic review" (Department for International Development (DFID), 2017: online). REAs, therefore, stem from Systematic Review methodology that, historically, focus on interventions and their effectiveness using experimental or quasi-experimental research design. By contrast, REAs are used to gain an overview of the prevalence and quality of evidence focusing on topic areas to support commissioning or programming decisions and identifying evidence gaps requiring further research (DFID, 2017: online) . An REA is conducted within a shorter timeframe than a Systematic Review but retains the key characteristics of systematic review; transparency, replicability and comprehensiveness (Government Social Research (GSR) and EPPI Centre, 2009; Galvani & Forrester, 2011; GSR, 2013) .
Our initial goal was establishing if there were any interventions for this group. As the review proceeded, the lack of a cohesive body of evidence to answer the research questions indicated became clear. Therefore, a combination of a REA and systematic mapping methodology (Clapton, Rutter, & Sharif, 2009 ) was adopted.
Systematic maps aim to describe the existing literature and gaps in the literature, in a broad topic area and the literature quality and content can be analysed in depth or more superficially as appropriate to individual projects (Clapton et al., 2009, p. 11) . The review, therefore, was conducted with the rigour of planning and approach of an REA. However, as a result of our experience conducting the REA and the diversity of the literature found, it also encompassed systematic mapping of the review's findings.
| Search methods
This REA was an iterative review, the findings of which sought to support the wider programme of research of which it was part. To ensure it did so, five separate protocols were developed for the ini- These original protocols for the review were adapted as the REA proceeded due to the very limited relevant data generated by them.
This strategy allowed us to refine the questions and the focus of the research once the review was being conducted. Subsequently, the search terms were broadened to capture all the literature within this field within our search parameters (see Table 1 ). An additional limiter was that the papers were written in English. We excluded tobacco-related studies. Excluded papers were coded A-E (see coding table below in Table 2 ). any disagreement, a third researcher would review the paper. Study commentaries were produced in an excel file to summarise key aspects of the papers in relation to the sub-group within which they were included. This included both key findings and/or recommendations that speak to the aims of this REA. In terms of quality control, each commentary was reviewed by a second researcher independently to assess the summary in relation to the original paper.
| Data extraction and synthesis
| Quality appraisal
The quality of the individual studies was assessed based on six principles derived from DFID guidance, each of which have a number of quality related questions within the principles (DFID, 2014). The empirical studies in the evidence base were scored on all six criteria on a three-point scale reflecting the extent to which the studies followed good research practice: 3 = no concerns; 2 = some minor concerns; 1 = major concerns. This resulted in a score ranging from 6 to 18 for each study. Studies were then assigned a quality category of high, moderate or low, based on their score. It is important to note that a low or moderate "quality" rating does not imply that a study was poorly designed or executed and does not suggest that its conclusions are incorrect or unreliable. It can simply mean that the report of the study did not fully explain its design or methods.
| FINDING S
The initial search of peer-reviewed articles resulted in a large number of papers. The inclusion and exclusion criteria were applied at abstract and full text reading stages (see Figure 1 below ).
There were 60 papers generated from our search after applying the inclusion and exclusion criteria. They were, however, extremely diverse in methodology, focus and audience. The systematic map (Figure 2 ) illustrates the range of evidence found among the 60 papers.
All empirical studies (n = 32) referred to in this REA were scored according to the DFID (2014) guidance (Table 3) . Table 3 summarises the evidence base found for this REA in terms of types of study and quality.
The majority of papers found were published in the last decade and were North American (USA or Canadian) in origin. Just over half were based on empirical research of some kind with more quantitative data than qualitative data presented. The greater number of journal articles compared to other sources was a result of our search strategy which focussed on published research. As with other new areas of research, for example sight loss and substance use (Galvani, Livingston, & Morgan, 2016) , there were a number of clinical case studies presented in the literature. The final list of papers is included at the end of this paper in Table 4 . 
| Thematic groups
As the systematic map shows, the topic focus of the evidence could be grouped around three main themes: pain management (n = 25), homeless and miscellaneous populations (n = 24) and alcohol-related papers (n = 6). In addition, five remaining papers were diverse in focus and methodology.
| Pain management
Pain management was, marginally, the largest category to emerge from the peer-reviewed literature. The majority (n = 23) were from the USA with the other single papers from Canada and the UK. The studies ranged from clinical chart/note reviews (Barclays et al., 2014; Childers et al., 2015; Kwon et al., , 2015 Rowley et al., 2011) , to small scale case study reviews (Arthur et al., 2016; Burton-MacLeod et al., 2008; Farnham, 2012; Kirsh & Passik, 2006; Koyyalagunta et al., 2011; Kutzen, 2004; Walsh & Broglio, 2010) . There was also one integrated literature review (Carmichael et al., 2016) examining assessment and risk in relation to opioid misuse within cancer care and two systematic reviews (Chou et al., 2009; Taveros & Chuang, 2016) . In terms of the populations of interest, the majority of papers (n = 13) were within a context of pain in cancer care (Arthur et al., 2016; Barclay et al., 2014 , Burton-MacLeod et al., 2008 Carmichael et al. 2016; Childers et al., 2015; Kirsh & Passik, 2006; Koyyalagunta et al., 2011; Kwon et al., , 2015 Passik et al., 2009; Rowley et al., 2011; Taveros & Chuang, 2016; Walsh & Broglio, 2010) . One study examined pain in prison popula- The other studies examined problematic substance use from a general palliative care context (Childers & Arnold, 2012 , Farnham, 2012 Krashin et al., 2015; Pancari & Baird, 2014 , Riesfield et al., 2009 Tan et al., 2014) with two studies focussing on chronic noncancer pain (Chou et al., 2009; Krashin et al., 2012) . A number of papers acknowledged both the complexity of pain management and persistent issues of under-treatment of patients with substance misuse issues (Farnham, 2012; Koyyalagunta et al., 2011; Krashin et al., 2015; Kwon et al., 2015; Lum, 2003; Passik et al., 2009; Rowley et al., 2011; Walsh & Broglio, 2010; Williams et al., 2014) . This led most papers to emphasise the need for comprehensive assessment as an essential step in managing pain in people using substances, requiring active engagement from the clinician. 
| Homeless populations
The majority of papers in this thematic group focussed on home- Country (n = 60) USA (n = 34) 56.7% Canada (n = 12) 20% UK (n = 9) 15% Australia (n = 3) 5% Italy (n = 1) 1.6% Sweden (n = 1) 1.6%
Type of Publication (n = 60) Journal Article (n = 58) 96.7% Book chapter (n = 2) 3.2% Content (n = 60) Pain management (n = 25) 41.6 % Homelessness and marginalised groups (n =24 ) 40% Alcohol related (n = 6 ) 10%
Other (n = 5) 8.3%
Empirical/Unempirical (n = 60) Empirical (n = 32) 53.3 % Unempirical (n = 28) 46.6%
Qualitative/Quantitative/Mixed
Methods (n = 32) Qualitative (n = 11) 34.3% Quantitative (n = 21) 65.6% Mixed (n = 0)
Type of Study (n = 32) EMPIRICAL Cross sectional (n = 6) 18.7%
Focus groups (n = 2) 6.2% Interview (n = 9) 28.1% Survey (n =6) 18.7%
Retrospective Chart review (RCR) (n = 9) 28.1%
Type of Study (cont.) UNEMPIRICAL (n= 28) Case study (n =10) 35.7% Description of practice (n =8) 28.5%
Literature review (n = 5) 17.8% Systematic review (n=3) 10.7% Book chapter (n=2) 7.1% 
| Mental Health, HIV and miscellaneous groups
Mental ill health was highlighted in many of the papers identified in this review. Depression is known to be associated with chronic and terminal illness and with pain, both as a factor in causation and arising as a consequence of illness ( 
| Alcohol
There were six papers identified that had alcohol as a primary focus (Dev et al., 2011; Irwin et al., 2005; Kwon et al., 2013b; Mercadante et al., 2015; Poonja et al., 2014; Webber & Davies, 2012) . Five of the papers examined alcohol use in relation to cancer and one related to liver cirrhosis. Men form the overwhelming majority of problematic alcohol users; usually by a factor of more than 2:1 and this continues into the palliative/advanced cancer population. This gender bias was reflected in the populations of the existing evidence on alcohol and end of life care. However, problematic alcohol use appears to be more common in younger palliative populations referred late to supportive palliative care services (Kwon et al., 2013b) . The most frequently used alcohol screening instrument documented in the evidence to date appears to be the CAGE questionnaire (Dev et al., 2011; Kwon et al., , 2015 Mercadante et al., 2015) although (8) 
| Miscellaneous
There were five papers that fell outside of the thematic groups identified. Beynon, McVeigh, Hurst, and Marr (2010) 
| D ISCUSS I ON
There is a lack of diversity, quality, breadth and depth to the litera- There were few prevalence studies identified. This is an area requiring more epidemiological research to provide a wider context for policy and practice development. In terms of methodological inquiry, more quantitative approaches are needed to provide larger scale data on the experiences of particular populations involved in service provision, e.g. palliative care social workers, community nurse provision.
Further research is needed on conditions other than cancer that co-exist with substance use, both in terms of their prevalence and incidence and also the health and social care responses available to people with experience of both substance use and life limiting illness. There are a wide range of co-morbidities associated with substance use, including COPD, diabetes, cardiovascular disease, mental health problems and liver disease (Cullen, O'Brien, O'Carroll, O'Kelly, & Bury, 2009; Shield et al., 2014 effectiveness. Aldridge et al. (2017) and Luchenski et al. (2018) (Rolfe, Ramsden, Banner, & Graham, 2018) .
A clear representation of people with problematic substance use can
give diverse perspectives to design relevant and appropriate studies and enhance sustainability (Wilson et al., 2015) . Research should also include the experiences, views and attitudes of social and healthcare professionals in responding to the overlapping issues of substance use and palliative and end of life conditions. This could include concerns about potential safety risks for outreach or community-based practice in particular, as highlighted by Galvani, Dance, and Wright (2018) in their study of hospice and specialist substance use staff. Lastly, there was limited evidence found in relation to alcohol (for example, problematic alcohol consumption associated with liver cirrhosis specifically at the end of life). Further work needs to be done in this area given alcohol remains the most commonly used substance. The full REA report for this work can be accessed for further information (Witham, Galvani, & Peacock, 2018) .
| Limitations
REAs have a number of limitations including the breadth and depth of the searching. The number and type of databases used for searching are often limited to allow for a more rapid result and usually do not include the comprehensive searching involved in systematic reviews (, undated). These limitations apply to this This is clearly an area of work where far more research is needed. It is a new area of work and research focus and that has to be considered in considering our findings. However, the gaps identified are considerable and need to be filled in order to provide an evidence base on which to build future good policy and practice, both in the UK and internationally. Ultimately, this work is needed to ensure that this growing group of people have good quality care and equal access to service provision.
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